A member of the class of benzimidazoles carrying a carboxy group at unspecified position.
ChEBI ID: 35688
| Member | Definition | Role |
|---|---|---|
| azilsartan | A benzimidazolecarboxylic acid that is benzimidazole-7-carboxylic acid substituted at position 2 by a methoxy group and at position 1 by a 2'-[(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl group. Used (as the prodrug, azilsartan medoxomil) for treatment of hypertension. | azilsartan |
| candesartan | A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. | candesartan |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 164 (8.27) | 18.2507 |
| 2000's | 1,020 (51.41) | 29.6817 |
| 2010's | 676 (34.07) | 24.3611 |
| 2020's | 124 (6.25) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 437 (21.29%) | 5.53% |
| Reviews | 196 (9.55%) | 6.00% |
| Case Studies | 72 (3.51%) | 4.05% |
| Observational | 10 (0.49%) | 0.25% |
| Other | 1,338 (65.17%) | 84.16% |